Skip to main content

Emili Montserrat MD

Emili Montserrat graduated in Medicine at the University of Salamanca (Spain) (1969) and obtained his MD, PhD certificate at the University of Barcelona (Spain) (1974). His professional career has developed at the Hôpital Saint Louis, Paris (France) (1973-1974) and afterwards at the Hospital Clinic from Barcelona (Spain) where he has been Head of the Department of Hematology and Chairman of the Institute of Hematology and Oncology.

Emili Montserrat is now Professor of Medicine Emeritus (University of Barcelona) at the Institute of Hematology and Oncology, Hospital Clínic, University of Barcelona. His main areas of interest are chronic lymphoproliferative disorders and lymphomas. Emili Montserrat is one of the founding members of the International Workshop on Chronic Lymphocytic Leukemia (IWCLL), the European Hematology Association (EHA) of which he has also been President, and the Society of Hematologic Oncology (SOHO). He is board member and past-president of the European Research Initiative on CLL (ERIC).

Emili Montserrat is on the board of the most important journals of hematology and oncology. He is section editor for CLL in the European Journal of Haematology and has received many awards, including the Lilly Award in Biomedicine, European Society of Medicial Oncology Life-time Achievement Award, National Award in Oncology (Fundación Echevarne, Spain), Rai-Binet (IWCLL) Medal, and Distinguished Senior Investigator of the University of Barcelona. Emili Montserrat is also honorary member of many universities and scientific organizations, among them the Royal College of Pathology (London, UK). Emili Montserrat has been appointed Doctor Honoris Causa by the University of Athens, Greece, and is honorary member of many scientific societies across the world. He is author or more than 300 scientific papers and 30 books and book chapters, mainly on CLL and lymphoma. He regularly participates as invited speaker to deliver conferences on his areas of interests at major international meetings such as the American Society of Hematology or the European Hematology Association, among others.

Emili Montserrat is a regular reviewer for journals such as Journal of Clinical Oncology, Blood, Lancet Oncology, Hematologica, Leukemia, and Lancet Hematology. He is also advisor of international research agencies such as the Italian Institute for Cancer, French Cancer Institute, and Instituto Carlos III (Spain).